Announcements Trials
Browse Landscape

Phase

Phase 2 22Phase 1 11Phase 3 8Phase 1/2 7Phase NA 2Phase EARLY_PHASE1 2Phase 4 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Tumor-Agnostic 1Dermatologic 1

Conditions

Neoplasms 1Melanoma 1

Interventions

Exercise 418Blood Specimen Collection 317Standard of Care 295Surveys and Questionnaires 241Radiosurgery 239Magnetic Resonance Spectroscopy 232Educational Status 222Methods 219Radiotherapy 216Early Intervention, Educational 199Practice Guidelines as Topic 140Interviews as Topic 139Biopsy 125Surgical Procedures, Operative 119Drug Therapy 119Acupuncture Therapy 119Control Groups 115Therapeutics 100Palliative Care 97Resistance Training 93Counseling 88Saline Solution 87Magnetic Resonance Imaging 84Cyclophosphamide 83Cisplatin 73Radiofrequency Ablation 71Cognitive Behavioral Therapy 71Specimen Handling 70Radiotherapy, Intensity-Modulated 68Colonoscopy 65

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × OTHER × Introns × Clear all
NCT06450145 2024-06-10

APL

Zhejiang Provincial People's Hospital

Phase NA Recruiting
15 enrolled
Tumor-Agnostic

Neoplasms

NCT01460875 2018-11-02

Recombinant Interferon Alfa-2b in Treating Patients With Melanoma

Ohio State University Comprehensive Cancer Center

Phase NA Completed
34 enrolled 12 charts
Dermatologic

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡